| Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation JU Peled, ALC Gomes, SM Devlin, ER Littmann, Y Taur, AD Sung, ... New England Journal of Medicine 382 (9), 822-834, 2020 | 548 | 2020 |
| Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy R Shouval, A Alarcon Tomas, JA Fein, JR Flynn, E Markovits, S Mayer, ... Journal of clinical oncology 40 (4), 369-381, 2022 | 97 | 2022 |
| Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells M Pennisi, M Sanchez-Escamilla, JR Flynn, R Shouval, A Alarcon Tomas, ... Blood Advances 5 (17), 3397-3406, 2021 | 95 | 2021 |
| CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results JH Park, K Nath, SM Devlin, CS Sauter, ML Palomba, G Shah, P Dahi, ... Nature medicine 29 (7), 1710-1717, 2023 | 61 | 2023 |
| Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma J Zurko, J Ramdial, M Shadman, S Ahmed, A Szabo, L Iovino, AA Tomas, ... Haematologica 108 (1), 98, 2023 | 53 | 2023 |
| Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma A Alarcon Tomas, JA Fein, S Fried, JR Flynn, SM Devlin, WB Fingrut, ... Leukemia 37 (1), 154-163, 2023 | 40 | 2023 |
| Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy H Hubbeling, EA Silverman, L Michaud, AA Tomas, R Shouval, J Flynn, ... Transplantation and cellular therapy 29 (4), 259. e1-259. e10, 2023 | 29 | 2023 |
| Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy K Wudhikarn, AA Tomas, JR Flynn, SM Devlin, J Brower, V Bachanova, ... Blood Advances 7 (13), 3192-3198, 2023 | 26 | 2023 |
| The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT R Shouval, JA Fein, C Cho, ST Avecilla, J Ruiz, AA Tomas, ... Blood Advances 6 (5), 1525-1535, 2022 | 26 | 2022 |
| Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients SS Mahmood, PA Riedell, S Feldman, G George, SA Sansoterra, ... European Heart Journal 44 (22), 2029-2042, 2023 | 21 | 2023 |
| The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients RJ Lin, L Michaud, SM Lobaugh, R Nakajima, A Mauguen, TA Elko, ... Leukemia & lymphoma 61 (8), 1833-1841, 2020 | 14 | 2020 |
| Novel agents may be preferable to chemotherapy for large B-cell lymphoma progressing after CD19-CAR-T: a multicenter observational study AA Tomas, JA Fein, S Fried, W Fingrut, T Anagnostou, A Alperovich, ... Blood 138, 883, 2021 | 13 | 2021 |
| Allogeneic hematopoietic cell transplantation after chimeric antigen receptor T cell therapy in large B cell lymphoma S Fried, R Shouval, M Walji, JR Flynn, R Yerushalmi, N Shem-Tov, ... Transplantation and cellular therapy 29 (2), 99-107, 2023 | 12 | 2023 |
| Infecciones por virus de la gripe y virus respiratorios IP Pascual, EM Rubio, AA Tomás, AR Martínez Medicine-Programa de Formación Médica Continuada Acreditado 12 (56), 3291-3297, 2018 | 12 | 2018 |
| Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma M Scordo, JR Flynn, M Gonen, SM Devlin, A Parascondola, AA Tomas, ... Blood Advances 7 (18), 5579-5585, 2023 | 11 | 2023 |
| EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation M Sanchez-Escamilla, J Flynn, S Devlin, M Maloy, SA Fatmi, AA Tomas, ... Bone marrow transplantation 58 (5), 498-505, 2023 | 9 | 2023 |
| Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome ST Bhaskar, VG Patel, DL Porter, SJ Schuster, LJ Nastoupil, MA Perales, ... Blood advances 7 (17), 4765-4772, 2023 | 8 | 2023 |
| Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma RJ Lin, SJ Kim, S Brown, TA Elko, JD Ruiz, DM Hanley, M Lia Palomba, ... Blood Advances 7 (14), 3501-3505, 2023 | 7 | 2023 |
| Pre-transplant fecal microbial diversity independently predicts critical illness after hematopoietic cell transplantation FI Adhi, ER Littmann, Y Taur, MA Maloy, KA Markey, E Fontana, ... Blood 134, 3264, 2019 | 5 | 2019 |
| Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation RJ Lin, RE Baser, TA Elko, B Korc-Grodzicki, A Shahrokni, MA Maloy, ... Bone marrow transplantation 56 (1), 289-292, 2021 | 4 | 2021 |
